Urgent.News

One page, thousands of outlets. See who else covered it.

Editions

Health & Medicine

SBRT Misses the Mark in Prostate Cancer Trial

(MedPage Today) -- Stereotactic body radiotherapy (SBRT) for localized prostate cancer did not improve urinary irritation or disease-free-survival (DFS) compared with hypofractionated intensity-modulated radiotherapy (IMRT), a large randomized...

SBRT Misses the Mark in Prostate Cancer Trial

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Tuesday 18 August →